Skip to main content
PMC home page
Redox Report : Communications in Free Radical Research logoLink to Redox Report : Communications in Free Radical Research
. 2013 Jul 19;15(6):259–267. doi: 10.1179/135100010X12826446921707

Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine

Diana Couto 1, Daniela Ribeiro 1, Marisa Freitas 1, Ana Gomes 1, José L F C Lima 1, Eduarda Fernandes 2
PMCID: PMC7067340  PMID: 21208525

Abstract

Sulfasalazine is a prodrug composed by a molecule of 5-aminosalicylic acid (5-ASA) and sulfapyridine (SP), linked by an azo bond, which has been shown to be effective in the therapy of inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease, as well as of rheumatic diseases, such as rheumatoid arthritis and ankylosing spondylitis. The precise mechanism of action of sulfasalazine and/or its metabolites has not been completely elucidated, though its antioxidant effects are well established and are probably due to its scavenging effects against reactive oxygen and nitrogen species (ROS and RNS), as well as metal chelating properties, in association to its inhibitory effects over neutrophil oxidative burst. The present work was focused on screening and comparing the potential scavenging activity for an array of ROS (O2•–, H2O2, 1O2, ROO• and HOCl) and RNS (•NO and ONOO–), mediated by sulfasalazine and its metabolites 5-ASA and SP, using validated in vitro screening systems. The results showed that both 5-ASA and sulfasalazine were able to scavenge all the tested ROS while SP was practically ineffective in all the assays. For HOCl, 1O2, and ROO•, 5-ASA showed the best scavenging effects. A new and important finding of the present study was the strong scavenging effect of 5-ASA against 1O2. 5-ASA was shown to be a strong scavenger of •NO and ONOO–. Sulfasalazine was also able to scavenge these RNS, although with a much lower potency than 5-ASA. SP was unable to scavenge •NO in the tested concentrations but was shown to scavenge ONOO–, with a higher strength when the assay was performed in the presence of 25 mM bicarbonate, suggesting further scavenging of oxidizing carbonate radical. In conclusion, the ROS- and RNS-scavenging effects of sulfasalazine and its metabolites shown in this study may contribute to the anti-inflammatory effects mediated by sulfasalazine through the prevention of the oxidative/nitrative/nitrosative damages caused by these species.

Keywords: SULFASALAZINE, SULFAPYRIDINE, 5-AMINOSALICYLIC ACID, REACTIVE OXYGEN SPECIES, REACTIVE NITROGEN SPECIES, SCAVENGING ACTIVITY

Full Text

The Full Text of this article is available as a PDF (440.5 KB).

REFERENCES

  • 1.Nielsen OH, Munck LK. Drug insight: aminosalicylates for the treatment of IBD. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 160–170. [DOI] [PubMed] [Google Scholar]
  • 2.Nikfar S, Rahimi R, Rezaie A, Abdollahi M. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Dig Dis Sci 2009; 54: 1157–1170. [DOI] [PubMed] [Google Scholar]
  • 3.Plosker GL, Croom KF. Sulfasalazine: a review of its use in the management of rheumatoid arthritis. Drugs 2005; 65: 1825–1849. [DOI] [PubMed] [Google Scholar]
  • 4.Donahue KE, Gartlehner G, Jonas DE et al. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med 2008; 148: 124–134. [DOI] [PubMed] [Google Scholar]
  • 5.Reed MR, Taylor AL. Tumour necrosis factor inhibitors in ankylosing spondylitis. Intern Med J2009; 38: 781-789. [DOI] [PubMed] [Google Scholar]
  • 6.Stenson WF, Lobos E. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J C1M Invest 1982; 69: 49–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hawkey CJ, Truelove SC. Inhibition of prostaglandin synthetase in human rectal mucosa. Gut 1983; 24: 213–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levelsdetermined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986; 91: 837–844. [DOI] [PubMed] [Google Scholar]
  • 9.Barrera P, Boerbooms AM, van der Putte LB, van der Meer JW. Effects of antirheumatic agents on cytokines. Semin Arthritis Rheum 1996; 25: 234–253. [DOI] [PubMed] [Google Scholar]
  • 10.Hirohata S, Ohshima N, Yanagida T, Aramaki K. Regulation of human B cell function by sulfasalazine and its metabolites. Int Immunopharmacol 2001; 2: 631–640. [DOI] [PubMed] [Google Scholar]
  • 11.Shanahan F, Niederlehner A, Carramanzana N, Anton P. Sulfasalazine inhibits the binding of TNF alpha to its receptor. Immunopharmacology 1990; 20: 217–224. [DOI] [PubMed] [Google Scholar]
  • 12.Egan LJ, Mays DC, Huntoon CJ et al. Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem 1999; 274: 26448–26453. [DOI] [PubMed] [Google Scholar]
  • 13.Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K. Mesalazine inhibits activation of transcription factor NF-03 in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol 2000; 95: 3452–3457. [DOI] [PubMed] [Google Scholar]
  • 14.Burress GC, Musch MW, Jurivich DA, Welk J, Chang EB. Effects of mesalamine on the hsp72 stress response in rat IEC-18 intestinal epithelial cells. Gastroenterology 1997; 113: 1474–1479. [DOI] [PubMed] [Google Scholar]
  • 15.Ahnfelt-Ronne I, Nielson OH, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1990; 98: 1162–1169. [DOI] [PubMed] [Google Scholar]
  • 16.Desreumaux P, Ghosh S. Review article: mode of action and delivery of 5-aminosalicylic acid-new evidence. Aliment Pharmacol Ther 2006; 241: S2–S9. [DOI] [PubMed] [Google Scholar]
  • 17.Dallegri F, Ottonello L, Ballestrero A, Bogliolo F, Ferrando F, Patrone F. Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. Gut 1990; 31: 184–186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Prakash A, Markham A. Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease. Drugs 1999; 57: 383–408. [DOI] [PubMed] [Google Scholar]
  • 19.Sandoval M, Liu X, Mannick EE, Clark DA, Miller MJ. Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. Gastroenterology 1997; 113: 1480–1488. [DOI] [PubMed] [Google Scholar]
  • 20.Craven PA, Pfansteil J, Saito R, DeRubertis FR. Actions of sulfasalazine and 5-aminosalicylic acid reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity. Gastroenterology 1987; 92: 1998–2008. [DOI] [PubMed] [Google Scholar]
  • 21.Kvietys PR, Morgan-Smith S, Grisham MB, Manci EA. 5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat. Gastroenterology 1988; 94: 733–738. [DOI] [PubMed] [Google Scholar]
  • 22.Del Soldato P, Campieri M, Brignola C et al. A possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: interaction with oxygen free radicals. Gastroenterology 1985; 189: 1215–1216. [DOI] [PubMed] [Google Scholar]
  • 23.Ahnfelt-Ronne I, Nielson OH. The anti-inflammatory moiety of sulfasalasine, 5-aminosalacilic acid, is radical scavenger. Agents Actions 1987; 21: 191–194. [DOI] [PubMed] [Google Scholar]
  • 24.Ahnfelt-Ronne I, Nielson OH, Bukhave K, Elmgreen J. Sulfasalazine and its anti-inflammatory metabolite 5-aminosalicylic acid: effect arachidonic acid metabolism in human neutrophils, and free radical scavenging. Adv Prostaglandin Thromboxane Leukotriene Res 1987; 17B: 918–922. [PubMed] [Google Scholar]
  • 25.Aruoma OI, Wasil M, Halliwell B, Hoey MB, Butler J. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol 1987; 36: 3739–3742. [DOI] [PubMed] [Google Scholar]
  • 27.Kanerud L, Hafstrom I, Ringertz B. Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium. Ann Rheum Dis 1990; 49: 296–300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Neal TM, Winterbourn CC, Vissers MCM. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Biochem Pharmacol 1987; 36: 2765–2768. [DOI] [PubMed] [Google Scholar]
  • 28.Joshi R, Kumar S, Unnikrishnan M, Mukherjee T. Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity. Free Radic Res 2005; 39: 1163–1172. [DOI] [PubMed] [Google Scholar]
  • 29.Fernandes E, Toste SA, Lima JLFC, Reis S. The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species. Free Radic Rio! Med 2003; 35: 1008–1017. [DOI] [PubMed] [Google Scholar]
  • 30.Fernandes E, Costa D, Toste SA, Lima JLFC, Reis S. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Rio! Med 2004; 37: 1895–1905. [DOI] [PubMed] [Google Scholar]
  • 31.Costa D, Gomes A, Reis S, Lima JLFC, Fernandes E. Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. Life Sci 2005; 76 :2841–2848. [DOI] [PubMed] [Google Scholar]
  • 32.Costa D, Vieira A, Fernandes E. Dipyrone and aminopyrine are effective scavengers of reactive nitrogen species. Redox Rep 2006; 11: 136–142. [DOI] [PubMed] [Google Scholar]
  • 33.Costa D, Moutinho L, Lima JLFC, Fernandes E. Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non-steroidal anti-inflammatory drugs. Biol Pharm Bull 2006; 29: 1659–1670. [DOI] [PubMed] [Google Scholar]
  • 34.Costa D, Gomes A, Lima JLFC, Fernandes E. Singlet oxygen scavenging activity by non-steroidal anti-inflammatory drugs. Redox Rep 2008; 13: 153–160. [DOI] [PubMed] [Google Scholar]
  • 35.Gomes A, Fernandes E, Silva AM et al. 2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species. Bioorg Med Chem 2007; 15: 6027–6036. [DOI] [PubMed] [Google Scholar]
  • 36.Whiteman M, Ketsawatsakul U, Halliwell B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann NY Acad Sci 2002; 962: 242–259. [DOI] [PubMed] [Google Scholar]
  • 37.Kettle AJ, Winterbourn CC. Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs. Biochem Pharmacol 1991; 41: 1485–1492. [DOI] [PubMed] [Google Scholar]
  • 38.Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr Opin Hematol 2000; 7: 53–58. [DOI] [PubMed] [Google Scholar]
  • 39.Liu ZC, McClelland RA, Uetrecht JP. Oxidation of 5-aminosalicylic acid by hypochlorous acid to a reactive iminoquinone. Possible role in the treatment of inflammatory bowel diseases. Drug Metab Dispos 1995; 23: 246–250. [PubMed] [Google Scholar]
  • 40.Steinbeck MJ, Khan AU, Kamovsky MJ. Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. J Biol Chem 1992; 267: 13425–13433. [PubMed] [Google Scholar]
  • 41.Molin L, Stendahl O. The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis. Acta Med Scand 1979; 206: 451–457. [DOI] [PubMed] [Google Scholar]
  • 42.Stenson WF, Mehta J, Spilberg I. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (fMLP) to its receptor on human neutrophils. Biochem Pharmacol 1984; 33: 407–412. [DOI] [PubMed] [Google Scholar]
  • 43.Miyachi Y, Yoshioka A, Imamura S, Niwa Y. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut 1987; 28: 190–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Radi R, Cosgrove TP, Beckman JS, Freeman BA. Peroxynitrite-induced luminol chemiluminescence. Biochem J1993; 290: 51-57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Denicola A, Freeman BA, Trujillo M, Radi R. Peroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite-mediated oxidations. Arch Biochem Biophys 1996; 333: 49–58. [DOI] [PubMed] [Google Scholar]
  • 46.Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 1998; 25: 392–403. [DOI] [PubMed] [Google Scholar]

Articles from Redox Report : Communications in Free Radical Research are provided here courtesy of Taylor & Francis

RESOURCES